Use of preimplantation factor peptides to treat intolerence to embryo implantation

摘要

Disclosed is the use of one or more PIF peptides in the manufacture of a medicament for treating intolerance to embryo implantation in a subject, wherein said medicament is administered to said subject in need thereof. The enhancement of endometrial receptivity can be measured by an increase in beta-3 integrin expression.